Project presentation in the frame of the Research Participants Loyalty program

The 3rd Loyalty Meeting for research participants and collaborators of the Barcelonaβeta Brain Research Center (BBRC) took place on April 18th in Barcelona, Spain. The aim of these annual meetings, organised by the Pasqual Maragall Foundation, is to share their knowledge with their research participants and collaborators, as well as to increase their loyalty. Over 1,500 people attended this edition,…

Collaboration is key for two-day meeting convened by Innovative Medicines Initiative

“Collaboration in Alzheimer’s disease and beyond: the present and future of IMI initiatives in neurodegeneration” was the theme of the meeting organised by the Innovative Medicines Initiative. It brought together the complete portfolio of IMI projects in the Alzheimer’s/dementia fiels, as well as other key stakeholder organisations and initiatives from Europe and beyond. The goal of…

EPAD project launches introduction video on its website

  On 10 March, the European Prevention of Alzheimer’s Dementia (EPAD) project launched its first video – an introduction to the project. The three and a half minute animated video is available on the EPAD website homepage: http://ep-ad.org/ EPAD is a collaborative research effort to improve the chance of successfully preventing Alzheimer’s dementia and to…

EPAD paper offers recommendations for the success of readiness cohorts in Alzheimer’s disease research

Summary: There is growing interest in the development of novel approaches to secondary prevention trials in Alzheimer’s disease to facilitate screening and recruitment of research participants and to reduce the time and costs associated with clinical trials. Several international research collaborations are setting up research infrastructures that link existing research cohorts, studies or patient registries…

Could a dementia-free world become a reality?

Professor Craig Ritchie, EPAD coordinator and Director of the University of Edinburgh’s Centre for Dementia Prevention, gave his Inaugural Lecture on 20th February 2017, entitled “Could a dementia-free world become a reality?” The sold-out event was attended by academics, policy makers, research participants and school students, and provided a fascinating insight into the global landscape…

EPAD WP6 team makes plans for 2017

Members of the European Prevention of Alzheimer’s Dementia (EPAD) Work Package 6 (WP6) communication and dissemination team met on the Novartis Campus in Basel on 13 and 14 February. The team discussed the project’s communication strategy, focus plan and activities for 2017, and made plans for the EPAD General Assembly planned in May. The meeting…

Interview with Richard Milne

What is your current role in EPAD? I work on ethical and social questions related to the development of the EPAD project, conducting qualitative research and coordinating the work of the EPAD ‘ELSI’ (Ethical, Legal and Social Implications) group. This group, led by Shirlene Badger, Edo Richard, Luc Truyen and Carol Brayne, consists of clinicians, philosophers, social…

Interview with Sandra Pla

What is your current role in EPAD? With Carlos Díaz, we are co-leads of WP5 (Project Management) together with Janssen, being responsible for monitoring compliance to the work plan, planned resources and time schedule, deliverables and tracking milestone achievements, risk management, overall financial management (budget and costs/payments control) and administration. I am also participating in…

Looking back at an EPAD-tastic 2016!

Another EPAD year has passed and we are proud to look back at a lot of successful deliveries and established relationships and look forward to 2017. To celebrate turning two, we list herein some of our key achievements of the past 12 months. January At the turn of the year, we welcomed the 36th EPAD…

EPAD welcomes new partner Roche

We are pleased to announce the arrival of a new project partner, Roche. We say a warm welcome to Roche and look forward to our collaboration. The EPAD project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115736, resources of which are composed of financial contribution from the European…